Learn More
Medchemexpress LLC FHT-1015 | 2368903-18-6 | 98.4% | C25H25N5O4S3 | 100 MG

Supplier: Medchemexpress LLC HY144896100MG
FHT-1015 is a selective allosteric inhibitor of SMARCA4 and SMARCA2 ATPases, also known as BRG1 and BRM. It inhibits ATPase activity by inducing a conformational change in the BRG1/BRM protein. This compound interferes with tumor cell growth and migration, making it suitable for research in uveal melanoma and hematologic cancer. In vitro studies show inhibitory effects on MC38 and CT26 cells.
- Selective SMARCA4 (IC50 = 4 nM) and SMARCA2 (IC50 = 5 nM) inhibitor
- Allosteric inhibitor
- Interferes with tumor cell growth and migration
- Suitable for research in uveal melanoma and hematologic cancer
- Appears as a solid, white to off-white in color
- Soluble in DMSO at concentrations ≥ 100 mg/mL
- Molecular weight of 555.69
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.